The FOMC meeting wraps up today (Wednesday), and no one's expecting a miracle. There's only a 2.6% chance of a rate cut… essentially none. But every word from Powell matters, especially with inflation ...

Republicans are eyeing massive changes to America's healthcare system that could save $240 billion over ten years.

Tack on a half-dozen zeros to your CVS receipt and you'll get a sense of the sticker shock afflicting state officials, insurers and hospitals dealing with the soaring cost of prescription drugs in ...

Under the Inflation Reduction Act, medications with the same active ingredient will be treated as the same drug for price ...

A trade deal between the U.S. and the European Union will impose a 15% tariff on imported medications from Europe, setting the stage for potential cost increases for pharmaceuticals, The New York ...

Strong efficacy and cardiovascular benefits should allow Novo to continue growing sales of GLP-1 therapies in diabetes. Ozempic and Rybelsus helped Novo gain share over Eli Lilly's once-weekly ...

The administration, which is set to cut the subsidy for the drug benefit program by 40%, says it will negotiate with insurers to ease the financial strain to the millions of seniors on the plan. Plus, ...

The report, compiled for The New York Times by health analytics company Komodo Health, shows that denial rates rose from 18.3 ...

Editors: Story has been updated from original, with material from the president of the Arizona Obesity Organization. Slug: ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...